Quidel Corporation (QDEL)
After hours:
| Previous close | 42.40 |
| Open | 42.40 |
| Bid | 44.03 x 100 |
| Ask | 47.79 x 200 |
| Day's range | 41.56 - 44.17 |
| 52-week range | 37.78 - 89.11 |
| Volume | |
| Avg. volume | 948,757 |
| Market cap | 2.95B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -27.42 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.00 |
Business WireQuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
SAN DIEGO, May 23, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced that members of its management team are scheduled to participate in the 44th Annual William Blair Growth Stock Conference on June 5, 2024, in Chicago, IL.
Business WireQuidelOrtho Opens New Distribution Center in Pedricktown, NJ
SAN DIEGO, May 15, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s commitment to strengthening supply chain resilience and elevating the customer experience. In collaboration with a third-party logistics provider, this investment in redundancy and capacity is designed to enable QuidelOrtho to fulfill customer orders with agility.
- GuruFocus.com
QuidelOrtho Corp Reports Mixed Q1 2024 Results Amid Strategic Shifts and Market Challenges
Revenue Declines but Cost-Cutting Measures Show Promise
